谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.

Michael Benatar,Joanne Wuu,Peter M. Andersen,Robert C. Bucelli,Jinsy A. Andrews,Markus Otto,Nita A. Farahany,Elizabeth A. Harrington,Weiping Chen,Adele A. Mitchell,Toby Ferguson,Sheena Chew,Liz Gedney,Sue Oakley,Jeong Heo,Sowmya Chary,Laura Fanning,Danielle Graham,Peng Sun,Yingying Liu,Janice Wong,Stephanie Fradette

Neurotherapeutics（2022）

引用 77|浏览1
关键词
SOD1-ALS,Neurofilament,Genetic testing,Pre-fALS,Phenoconversion
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要